Acacia Diversified Holdings, Inc. ACCA OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score

30/100

0/4 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Acacia Diversified Holdings, Inc. (ACCA) .

Criteria proven by this page:

VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.

Overall SharesGrow Score: 27/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score

30/100

SG Score

View full scorecard →

—

VALUE

N/A

No coverage

—

FUTURE

N/A

No coverage

✗

PAST

0/100

→ Income

✗

HEALTH

50/100

Debt-to-Equity & liquidity

→ Health

✗

MOAT

11/100

→ Income

GROWTH

58/100

→ Income

—

INCOME

N/A

No coverage

Valuation Snapshot — ACCA

Valuation Multiples

P/E (TTM)0.0

Forward P/EN/A

PEG RatioN/A

Forward PEGN/A

P/B Ratio0.00

P/S Ratio0.00

EV/EBITDA0.0

Per Share Data

EPS (TTM)$0.00

Book Value / Share$0.00

Revenue / Share$0.00

FCF / Share$0.00

Yields & Fair Value

Earnings YieldN/A

Dividend Yield0.00%

EPS: Actual vs Estimates

Earnings Per Share (EPS) History

Year	EPS (Diluted)	Revenue	Net Income	Net Margin
2013	$-0.06	$147.88K	$-683.31K	-462.1%
2014	$-0.01	$1.41M	$-151.65K	-10.7%
2015	$-0.04	$255.51K	$-611.82K	-239.5%
2016	$-0.11	$311.28K	$-1.79M	-573.5%
2017	$-0.11	$478.23K	$-1.83M	-383.4%
2018	$-0.09	$415.05K	$-1.71M	-412.6%
2019	$-0.05	$519.22K	$-1.71M	-329.4%
2020	$0.00	$0.00	$0.00	-
2021	$0.00	$0.00	$0.00	-
2022	$0.00	$0.00	$0.00	-